助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   膀胱肿瘤标记物 的翻译结果: 查询用时:0.194秒
图标索引 在分类学科中查询
所有学科
泌尿科学
肿瘤学
更多类别查询

图标索引 历史查询
 

膀胱肿瘤标记物
相关语句
  “膀胱肿瘤标记物”译为未确定词的双语例句
     Currently there are few published reports of expression of both of serum and urinary VEGF in bladder cancer.
     目的研究VEGF在膀胱肿瘤患者的血清和尿液中表达情况,及其作为膀胱肿瘤标记物的价值。
短句来源
     Cells are usually in G_0 phase, when induced by some stimulus, such as growth factors, they grow from G1 phase into S phase.
     生长因子及其受体参与调节肿瘤细胞的增殖,是研究最多的膀胱肿瘤标记物,其中包括表皮生长因子及其受体,胰岛素样生长因子及其受体,血管内皮生长因子及其受体,转化生长因子及其受体等。
短句来源
     AIM To study the expression of CK20 in exfoliated urothelial cells of patients with bladder cancer and to evaluate it's clinical significane .
     作为一种新的膀胱肿瘤标记物,通过检测CK20的表达来研究移行细胞癌已成为目前的热点之一。
短句来源
     CONCLUSION: CK20 may be a good tumor marker for bladder cancer. RT PCR method has higher sensitivity and specificity and can be used in the diagnosis of bladder cancer.
     结论 :CK2 0是一种较为理想的膀胱肿瘤标记物 ,RT PCR方法检测膀胱癌尿液中CK2 0可用于膀胱癌的诊断
短句来源
     Conclusion Both serum and urinary bFGF are clinically relevant with bladder cancer, which may serve as a valuable tumor marker.
     结论 血液和尿液bFGF与膀胱肿瘤有密切关系 ,有望成为膀胱肿瘤标记物
短句来源
  相似匹配句对
     Bladder-preserving strategy for bladder tumor
     膀胱肿瘤保留膀胱的策略
短句来源
     Nontransitional cell tumor of the bladder
     膀胱非移行细胞肿瘤
短句来源
     THE ADVANCE OF MARKERS FOR THYROID NEOPLASM
     甲状腺肿瘤标记物研究进展
短句来源
     Tumor markers in patients,serum were all negative.
     血清肿瘤标记物均为阴性。
短句来源
     Detecting Specific Tumor Markers in Urine of Transitional Cell Carcinoma of Bladder by Proteomics Methods
     蛋白质组学方法检测膀胱移行细胞癌患者尿液中特异性肿瘤标记物
短句来源
查询“膀胱肿瘤标记物”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
没有找到相关例句


AIM: To study the expression of cytokeratin 20 in exfoliated urothelial cells of patients with bladder cancer and to evaluate its clinical significance. METHODS: Reverse transcriptase polymerase chain reaction (RT PCR)method was used to determine the expression of CK20 in exfoliated urothelial cells of 45 patients with bladder cancer and 18 patients with nonmalignant disease. RESULTS: Out of the 45 patients with bladder cancer, positive Ck20 was found in 39 patients and only in 1 out of the 18 patients...

AIM: To study the expression of cytokeratin 20 in exfoliated urothelial cells of patients with bladder cancer and to evaluate its clinical significance. METHODS: Reverse transcriptase polymerase chain reaction (RT PCR)method was used to determine the expression of CK20 in exfoliated urothelial cells of 45 patients with bladder cancer and 18 patients with nonmalignant disease. RESULTS: Out of the 45 patients with bladder cancer, positive Ck20 was found in 39 patients and only in 1 out of the 18 patients with nonmalignant disease. The RT PCR sensitivity was found to be 86.7% and its specificity was 94.4%. CK20 was positive in 24 of the 29 G1 patients, in 11 of the 12 G2 patients and in 4 of the 4 G3 patients. CK20 was not related to the tumor grades and stages. CONCLUSION: CK20 may be a good tumor marker for bladder cancer. RT PCR method has higher sensitivity and specificity and can be used in the diagnosis of bladder cancer.

目的 :以逆转录聚合酶链反应 (RT PCR)检测尿中膀胱移行癌细胞 ,研究尿脱落细胞中细胞角蛋白 2 0 (CK2 0 )的表达及其临床意义 .方法 :应用RT PCR方法检测 4 5例膀胱癌患者以及 18例非肿瘤患者的尿脱落细胞CK2 0 .结果 :4 5例膀胱癌 39例CK2 0表达阳性 ,非肿瘤组 18例中 1例CK2 0表达阳性 ,RT PCR方法检测膀胱癌尿脱落细胞中CK2 0敏感度 86 .7% ,特异度 94 .4 % .G1,G2 及G3 膀胱癌阳性率分别为82 .8% (2 4 /2 9) ,91.7% (11/12 ) ,10 0 .0 % (4 /4) ,各级间无显著差异 (P >0 .0 5 ) .CK2 0的表达同肿瘤的分期、分级无关 .结论 :CK2 0是一种较为理想的膀胱肿瘤标记物 ,RT PCR方法检测膀胱癌尿液中CK2 0可用于膀胱癌的诊断

Objective To investigate the role of serum and urinary measurements of basic fibroblast growth factor(bFGF) in the diagnosis of patients with bladder cancer. Methods Serum and urine from 63 patients were assayed using a commerically available bFGF by ELISA. Forty three patients had a bladder tumor and twenty others with no history of malignancy were taken as controls. Results Both median serum and urinary bFGF were markedly higher in patients with active bladder cancer than those in the controls( P <0.001)....

Objective To investigate the role of serum and urinary measurements of basic fibroblast growth factor(bFGF) in the diagnosis of patients with bladder cancer. Methods Serum and urine from 63 patients were assayed using a commerically available bFGF by ELISA. Forty three patients had a bladder tumor and twenty others with no history of malignancy were taken as controls. Results Both median serum and urinary bFGF were markedly higher in patients with active bladder cancer than those in the controls( P <0.001). The cut off value of serum bFGF≥3.95 pg/ml or urinary bFGF≥2.23 pg/mg were sensitive and specific for decection. Conclusion Both serum and urinary bFGF are clinically relevant with bladder cancer, which may serve as a valuable tumor marker.

目的 探讨血清和尿液中碱性成纤维细胞生长因子 (bFGF)浓度与膀胱肿瘤的临床意义。方法 采用酶联免疫吸附试验检测 4 3例经病理诊断确诊的膀胱肿瘤患者和 2 0例对照组 (包括 15例肾囊肿和尿道肉阜等良性疾病患者和5名健康者 )的血清和尿液bFGF水平。结果 膀胱肿瘤患者的血清和尿液bFGF水平均明显高于对照组 (P <0 .0 0 1) ,血清bFGF≥ 3.95 pg/ml和尿液bFGF≥ 2 .2 3pg/mg有较好的敏感性和特异性。 结论 血液和尿液bFGF与膀胱肿瘤有密切关系 ,有望成为膀胱肿瘤标记物

 
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关膀胱肿瘤标记物的内容
在知识搜索中查有关膀胱肿瘤标记物的内容
在数字搜索中查有关膀胱肿瘤标记物的内容
在概念知识元中查有关膀胱肿瘤标记物的内容
在学术趋势中查有关膀胱肿瘤标记物的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社